Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Compounding Chemotherapy Market Today And What Is Its Future Size?

The market size for compounding chemotherapy has seen robust expansion in the past several years. The projection is that it will rise from a valuation of $5.74 billion in 2024 to reach $6.11 billion in 2025, yielding a compound annual growth rate (CAGR) of 6.3%. This development during the historical period has been ascribed to factors such as the increasing rate of cancer occurrences, the growing implementation of hospital pharmacies, the escalating usage of antineoplastic agents, the escalating focus on patient-specific dosing, and the increased significance of oncology specialty clinics.

There is a prediction for robust expansion of the compounding chemotherapy market in the approaching years. The market is estimated to augment to $7.74 billion in 2029 with a compound annual growth rate (CAGR) of 6.1%. Various factors contributing to this growth during the forecast period are an increased emphasis on precision medicine, a high demand for orally and injectively administered chemotherapy compounds, growing utilization of hormonal and biologic agents in cancer treatment, an intensified focus on reducing medicine waste, and a surging demand for targeted cancer therapies. During the same period, key trends to be seen will likely include embracing technology in automated compounding devices, developing tailored chemotherapy dosing strategies, creation of mobile applications in support of chemotherapy workflow, integrating electronic health records (EHRs) with compounding systems, and incorporating barcode verification in compounding protocols.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25724&type=smp

What External And Internal Drivers Are Influencing The Compounding Chemotherapy Market?

The growth of the compounding chemotherapy market is expected to be propelled forward by the rising incidence of cancer. Cancer, defined as a cluster of diseases distinguished by the uncontrolled multiplication and dispersion of abnormal cells within the body, has seen an elevated occurrence primarily attributable to unhealthy habits. These include poor nutrition, lack of physical exercise, smoking, overconsumption of alcohol, and extensive exposure to environmental pollutants – all of which substantially enhance the risk of contracting various forms of cancer. Compounding chemotherapy aids in cancer treatment by facilitating personalized drug compositions specifically designed according to the needs of individual patients, thereby boosting effectiveness and decreasing side effects. For example, data released in July 2024 by the Australian Institute of Health and Welfare, a government agency in Australia, reported that in 2022, Australian cancer diagnoses totaled 160,570, indicating an increase of 3,789 cases from 156,781 in 2021. Consequently, the mounting occurrence of cancer instances stimulates the expansion of the compounding chemotherapy market.

How Is The Compounding Chemotherapy Market Categorized Across Applications And Types?

The compounding chemotherapy market covered in this report is segmented –

1) By Drug Type: Cytotoxic Drugs, Hormonal Agents, Immunomodulatory Agents, Targeted Therapies, Supportive Care Drugs

2) By Route Of Administration: Intravenous, Oral, Subcutaneous, Intramuscular, Intrathecal

3) By Technology: With Robotic Arms, Without Robotic Arms

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By Compounding Setting: Hospital Compounding, Compounding Pharmacies, Specialty Clinics, Homecare Settings

Subsegments:

1) By Cytotoxic Drugs: Alkylating Agents, Antimetabolites, Plant Alkaloids, Antitumor Antibiotics, Topoisomerase Inhibitors

2) By Hormonal Agents: Estrogen Antagonists, Androgen Deprivation Therapy Agents, Aromatase Inhibitors, Progestins, Gonadotropin-Releasing Hormone Agonists

3) By Immunomodulatory Agents: Immune Checkpoint Inhibitors, Monoclonal Antibodies, Interleukins, Cytokines, Immune System Activators

4) By Targeted Therapies: Tyrosine Kinase Inhibitors, Proteasome Inhibitors, Mammalian Target Of Rapamycin Inhibitors, Poly Polymerase Inhibitors

5) By Supportive Care Drugs: Antiemetics, Erythropoiesis-Stimulating Agents, Bone-Modifying Agents, Pain Management Drugs

How Are Market Trends Influencing Competition In The Compounding Chemotherapy Market?

Leading businesses in the compounding chemotherapy market are channeling their efforts into creating groundbreaking solutions such as robotic chemotherapy automation systems. These state-of-the-art tools are developed to precisely and safely create individualized chemotherapy doses, by automation of the compounding process, thus curbing the chance of human error and contamination. Simplivia Healthcare Ltd, a healthcare technology firm based in Israel, for instance, introduced their Smart Compounders Advanced Systems in February 2024. These systems manage the compounding of cytostatics and antibodies and can produce 20 to 40 preparations per hour. They involve automatic gravimetric verification and documentation to guarantee the highest precision. The systems significantly reduce the pharmacy workers’ contact with harmful substances and are designed to smoothly fit into current laminar airflow (LAF) cabinets or isolators, without necessitating any changes.

Who Are The Global Leaders Steering The Compounding Chemotherapy Market Forward?

Major companies operating in the compounding chemotherapy market are Baxter International Inc., Fresenius Kabi AG, Grifols S.A., Option Care Health Inc., ICU Medical Inc., Dedalus S.p.A., Fagron NV, BioScrip Inc., B. Braun Melsungen AG, Medisca Pharmaceutique Inc., Central Admixture Pharmacy Services Inc., Icon Group Holdings Pty Ltd, Avella Specialty Pharmacy, Stokes Healthcare Inc, McGuff Compounding Pharmacy Services Inc., Accord Healthcare Limited, Epicur Pharma LLC, Simplivia Healthcare Ltd., AmerisourceBergen Corporation, Kapsam Health Products Ltd., PharMEDium Services LLC.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/compounding-chemotherapy-global-market-report

What Are The Emerging Regional Trends Driving The Compounding Chemotherapy Market?

North America was the largest region in the compounding chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the compounding chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25724&type=smp

Browse Through More Reports Similar to the Global Compounding Chemotherapy Market 2025, By The Business Research Company

Chemotherapy At Home Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemotherapy-at-home-services-global-market-report

Generic Oncology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generic-oncology-drugs-global-market-report

Chemotherapy Induced Anemia Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model